The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease.
This two session course provides an understanding of the concepts that underlie precision cancer medicine and both its promise and limitations.
Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will explain how far we are able to use precision medicine by exploring the features of cancer we can target now, and where we might get to in the future, as well as looking at when precision medicine fails, and why expectations and realities don’t always align.
The course comprises two morning sessions delivered online via Microsoft Teams:
An introduction to the scientific concepts that underpin the concept of precision medicine looking at the features of cancer cells that we can target, the treatments available, and the tests and technologies needed to match targets with treatments. Includes the example of non-squamous, non-small cell lung cancer, where a precision approach is often already used.
The session focuses on the limitations and current realities of precision medicine. Elaine describes why a precision approach isn’t always possible, or might not give the best outcome, for every patient.
The session closes by exploring progress made in offering a precision-approach with three of the most common cancers: breast, bowel, and prostate, and considering where we go from here.
Delegates will be given access to recordings of all sessions for three months after completion of the course. If you are unable to attend a session the recording will ensure you can review any content you have missed.
By the end of this introduction to precision cancer medicine delegates will:
Dr Elaine Vickers, PhD of Science Communicated Ltd has worked as a cancer educator for over twenty years and has previously acted as science communicator for three of the UK’s leading medical research charities, including four years in the Science Information team at Cancer Research UK.
Elaine is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors, monoclonal antibodies and immunotherapies.
She is experienced in teaching people with any level of scientific or medical knowledge from cancer patients through to medical oncologists translating complex and often overwhelming topics into easily digestible and understandable knowledge, using colourful illustrations to explain scientific concepts.
Her book, A Beginner’s Guide to Targeted Cancer Treatments, was commended by the British Medical Association book awards. A second edition is due out in 2024.
This content is ideal for research nurses, clinical nurse specialists, pharmacists, and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with cancer, including junior doctors.
To book a place on this course go to Tickets at the bottom of the page.
At checkout you can make an online card payment or enter a coupon code to make alternative payment arrangements.
Alternative payment arrangements include:
Please see the Making payments & Coupons sections of the Help and FAQs.
